Brief: Monopar Announces Projected Timeline Of Upcoming Q1 2023 Data Events For Validive, Camsirubicin, And MNPR-101 RIT
26/01/2023 14:30
Jan 26 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR ANNOUNCES PROJECTED TIMELINE OF UPCOMING Q1 2023
DATA
EVENTS FOR VALIDIVE, CAMSIRUBICIN, AND MNPR-101 RIT
Source text for Eikon: ID:nGNXMTgPx
Further company coverage: MNPR.O
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla